Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection

According to the World Health Organization, approximately 150 million people worldwide are chronic carriers of hepatitis C virus (HCV). HCV infection can evolve into cirrhosis of the liver and its complications, which are ultimately responsible for more than 350,000 deaths every year. Antiviral ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Ivan, Buonomo, Antonio Riccardo, Zappulo, Emanuela, Minei, Giuseppina, Morisco, Filomena, Borrelli, Francesco, Coppola, Nicola, Borgia, Guglielmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079632/
https://www.ncbi.nlm.nih.gov/pubmed/25061308
http://dx.doi.org/10.2147/TCRM.S66731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079632/
https://www.ncbi.nlm.nih.gov/pubmed/25061308
http://dx.doi.org/10.2147/TCRM.S66731

Ejemplares similares